In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14020390
Abstract: Omicron was designated by the WHO as a VOC on 26 November 2021, only 4 days after its sequence was first submitted. However, the impact of Omicron on current antibodies and vaccines remains unknown and… read more here.
Keywords: analysis monoclonal; rbd rbd; rbd; silico analysis ... See more keywords